Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open-label Clinical Trial on the Effects of Intensive Versus Conventional Control of Ambulatory-determined Asleep Systolic Blood Pressure Mean on Cardiovascular, Metabolic, and Renal Disease Risks

NCT03457168 is registered in ClinicalTrials.gov with University of Vigo as lead sponsor.

NCT NCT03457168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03457168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open-label Clinical Trial on the Effects of Intensive Versus Conventional Control of Ambulatory-determined Asleep Systolic Blood Pressure Mean on Cardiovascular, Metabolic, and Renal Disease Risks
Lead sponsor
University of Vigo
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2019
Completion date
December 31, 2032
Enrollment
5,320 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension, systolic